| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-19 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |